Skip to main content
. 2024 Nov 27;9:237. doi: 10.1038/s41541-024-01030-8

Fig. 1. Schematic presentation of study design.

Fig. 1

Overall, 175 individuals with no history of previous rabies vaccination were initially included. All individuals received post-exposure prophylaxis (PEP) using the Institut Pasteur du Cambodge (IPC) regimen. A Participants were divided into two groups, RABV-exposed group and RABV-unexposed group. Groups were based on the result of RABV diagnostic or observation of the dog involved in bite incident. Laboratory diagnosis was performed using Direct Fluorescent Antibody Test (DFAT) on brain necropsy samples, and observation for clinical rabies signs was done for 10 days quarantine. Equine rabies immunoglobulin (eRIG) was provided in addition to vaccine to RABV-exposed group and RABV-unexposed group with severe bite, dead or disappeared dog. B PEP was administered at day 0 (D0), day 3 (D3) and day 7 (D7) with or without additional eRIG on D0. Blood samples were collected at baseline (D0; before vaccine administration), at day 7 (D7; last day of vaccination session), day 14 (D14; one week after PEP completion), month 6 (M6), and month 12 (M12) after the initial PEP vaccination. This figure was created using BioRender.com.